Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism.
Nasdaq: AGIO
    
Annual Reports & Proxy
 PDFView the 2015 Annual Report
 PDFView the 2016 Proxy Statement
Get help downloading or viewing the above file types
Electronic Voting

Over the Internet: Go to the website of Agios’ tabulator at www.proxyvote.com. Use the vote control number printed on your proxy card to access your account and vote your shares. You must specify how you want your shares voted or your Internet vote cannot be completed and you will receive an error message. Your shares will be voted according to your instructions. You must submit your Internet proxy before 11:59 p.m., Eastern Daylight Time, on June 20, 2016, the day before the annual meeting, for your proxy to be validly submitted over the Internet and your vote to count.

Beneficial Shareholders

If your shares of AGIO stock are held in a brokerage account or by a bank or other nominee, you are considered to be the “beneficial holder” of the shares held for you in what is known as “street name.”

Registered Shareholders

If your shares of AGIO stock are registered directly in your name with our transfer agent, you are considered to be a “registered shareholder.”

Related Links
Corporate Governance  | SEC Filings  | Contact Information